Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ropivacaine dose comparison in PCNL surgery
IRCT20220115053722N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in Lithiasis (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Sensory block level, Motor block level and 7 more. Started Jul 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
Lithiasis
Beyond the preview
Go deeper on IRCT20220115053722N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220115053722N1.